Taysha, UTSW start fund to speed up CNS gene therapies

By The Science Advisory Board staff writers

January 13, 2021 -- Taysha Gene Therapies and the University of Texas Southwestern Medical Center (UTSW) have launched a fund to accelerate the development of adeno-associated virus (AAV) gene therapies for monogenic diseases of the central nervous system (CNS).

Expanding this partnership supports the medical center's discovery efforts to bring about promising therapies while Taysha gets an exclusive option on new programs and intellectual property linked to this deal.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.